Search
for
Sort by
Research 61–90 of 1000+
- Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
- Analysis of LncRNA-mRNA Co-Expression Profiles in Patients With Polycystic Ovary Syndrome: A Pilot Study
- Exercise in the management of polycystic ovary syndrome: A position statement from Exercise and Sports Science Australia
- Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Treatment options for polycystic ovary syndrome
- COVID-19 and hypopituitarism
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- A Large Benign Adrenocortical Adenoma Cosecreting Testosterone and Cortisol
- Testosterone: The Male Sex Hormone
- Efficacy of metformin therapy in adolescent girls with androgen excess: relation to sex hormone–binding globulin and androgen receptor polymorphisms
- A guide to diagnosis and management of hypertrichosis
- Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Triglycerides, independent of Ferriman Gallwey Score, is a main determinant of free testosterone index in PCOS
- Polycystic ovary syndrome and its management: In view of oxidative stress
- Androgens/Androgen Receptor in the Management of Skin Diseases
- ENZYMES
- Research Relevant Conditions and Pathology in Nonhuman Primates
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Hyperandrogenism and Cardiometabolic Risk in Pre- and Postmenopausal Women—What Is the Evidence?
- Evidence-based approach to cutaneous hyperandrogenism in women
- Treatment guidelines in adult women
- Polycystic Ovarian Syndrome - What is New
- Evaluation of the role of soluble receptors for advanced glycosylated end-products in polycystic ovarian syndrome
- Aromatase inhibitor–induced hair loss in two adolescents
- Hyperandrogenism, Elevated 17-Hydroxyprogesterone and Its Urinary Metabolites in a Young Woman with Ovarian Steroid Cell Tumor, Not Otherwise Specified: Case Report and Review of the Literature
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Polycystic Ovarian Syndrome: Long-Term Health Consequences